UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2012-03, Vol.82 (4), p.1367-1375

2012

Volltextzugriff (PDF)

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2015-09, Vol.93 (1), p.29-36

2015

Volltextzugriff (PDF)

Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2015, Vol.91 (1), p.116-123

2015

Volltextzugriff (PDF)

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.738-746

2016

Volltextzugriff (PDF)

Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma

Diseases of the colon & rectum, 2003-04, Vol.46 (4), p.448-453

2003

Volltextzugriff (PDF)

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer

Journal of contemporary brachytherapy, 2014-10, Vol.6 (3), p.262-270

2014

Volltextzugriff (PDF)

A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer

International journal of radiation oncology, biology, physics, 2007-02, Vol.67 (2), p.445-452

2007

Volltextzugriff (PDF)

Adjuvant Vaginal Cuff Brachytherapy for High-Risk, Early Stage Endometrial Cancer: A Single-Institution Experience

Brachytherapy, 2014-03, Vol.13, p.S77-S78

2014

Volltextzugriff (PDF)

The use of mixed-integer programming for inverse treatment planning with pre-defined field segments

Physics in medicine & biology, 2002-07, Vol.47 (13), p.2235-2245, Article 304

2002

Volltextzugriff (PDF)

Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography

American journal of clinical oncology, 2016-04, Vol.39 (2), p.189-195

2016

Volltextzugriff (PDF)

Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)

International journal of radiation oncology, biology, physics, 2004-09, Vol.60 (1), p.302-309

2004

Volltextzugriff (PDF)

GSOR6 Presentation Time: 9:25 AM

Brachytherapy, 2022-11, Vol.21 (6), p.S52-S53

2022

Volltextzugriff (PDF)

GSOR6 Presentation Time: 9:25 AM: Integrating a Novel GYN Brachytherapy Workflow Using In-Room CBCT Images with MR-LINAC Scans

Brachytherapy, 2022-11, Vol.21 (6), p.S52-S53

2022

Volltextzugriff (PDF)

Inverse Planning for CT-Based High-Dose-Rate Brachytherapy of Cervical Cancer

Brachytherapy, 2010, Vol.9, p.S88-S89

2010

Volltextzugriff (PDF)

Abstract OT2-03-02: A pilot trial of hyperthermia in combination with olaparib in breast cancer patients with chest wall recurrences

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT2-03-02-OT2-03-02

2020

Volltextzugriff (PDF)

Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

World journal of oncology, 2024-06, Vol.15 (3), p.511-520

2024

Volltextzugriff (PDF)

Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal adenocarcinoma: long term outcome and implications for trial design

International journal of radiation oncology, biology, physics, 2015-12, Vol.94 (4), p.738-746

2015

Volltextzugriff (PDF)

Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature

Case reports in pancreatic cancer, 2015-11, Vol.1 (1), p.3-6

2015

Volltextzugriff (PDF)

NRG Oncology Radiation Therapy Oncology Group 0822: A phase II study of preoperative chemoradiotherapy utilizing intensity modulated radiation therapy (IMRT) in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer

International journal of radiation oncology, biology, physics, 2015-05, Vol.93 (1), p.29-36

2015

Volltextzugriff (PDF)

Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.91 (1), p.116-123

2014

Volltextzugriff (PDF)

Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer

Seminars in oncology, 2002-12, Vol.29 (6), p.80-83

ANNE, Pramila Rani

2002

Volltextzugriff (PDF)

The design and implementation of caloric restriction for oncology research (CaReFOR): Is starving cancer cells in the clinical realm feasible?

Hematology & Medical Oncology, 2017, Vol.2 (5)

2017

Volltextzugriff (PDF)

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer

Seminars in radiation oncology, 2002, Vol.12 (1), p.18-19

2002

Volltextzugriff (PDF)

RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanced Rectal Cancer

International journal of radiation oncology, biology, physics, 2011-07, Vol.82 (4), p.1367-1375

2011

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Humans
(16)
Oncology
(16)
Female
(12)
Middle Aged
(10)
Adult
(9)
Aged
(9)
Male
(9)
Radiology, Nuclear Medicine & Medical Imaging
(9)
Biological And Medical Sciences
(7)
Hematology, Oncology And Palliative Medicine
(7)
Medical Sciences
(7)
Radiology
(7)
Radiotherapy Dosage
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Chemotherapy
(5)
Radiology And Nuclear Medicine
(5)
Radiotherapy
(5)
Surgery
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

Eastern Cooperative Oncology Group and American College of Radiology Imaging Network Randomized Phase 2 Trial of Neoadjuvant Preoperative Paclitaxel/Cisplatin/Radiation Therapy (RT) or Irinotecan/Cisplatin/RT in Esophageal Adenocarcinoma: Long-Term Outcome and Implications for Trial Design

Longer time interval between completion of neoadjuvant chemoradiation and surgical resection does not improve downstaging of rectal carcinoma

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer

A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer

Adjuvant Vaginal Cuff Brachytherapy for High-Risk, Early Stage Endometrial Cancer: A Single-Institution Experience

The use of mixed-integer programming for inverse treatment planning with pre-defined field segments

Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography

Assessment and management of cutaneous reactions with amifostine administration: Findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP)

GSOR6 Presentation Time: 9:25 AM

GSOR6 Presentation Time: 9:25 AM: Integrating a Novel GYN Brachytherapy Workflow Using In-Room CBCT Images with MR-LINAC Scans

Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial

Inverse Planning for CT-Based High-Dose-Rate Brachytherapy of Cervical Cancer

Abstract OT2-03-02: A pilot trial of hyperthermia in combination with olaparib in breast cancer patients with chest wall recurrences

Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Eastern Cooperative Oncology Group (E1201) randomized phase II trial of neoadjuvant preoperative paclitaxel/cisplatin/radiotherapy (RT) or irinotecan/cisplatin/RT in esophageal adenocarcinoma: long term outcome and implications for trial design

Hepatoid Carcinoma of the Pancreas: A Case Report and Review of the Literature

NRG Oncology Radiation Therapy Oncology Group 0822: A phase II study of preoperative chemoradiotherapy utilizing intensity modulated radiation therapy (IMRT) in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer

Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer

Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer

The design and implementation of caloric restriction for oncology research (CaReFOR): Is starving cancer cells in the clinical realm feasible?

A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer

RTOG 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin with Concurrent Radiation Therapy for Patients with Locally Advanced Rectal Cancer

Suchergebnisse filtern